MedPath

CANCER INTELLIGENCE CARE SYSTEMS, INC.

CANCER INTELLIGENCE CARE SYSTEMS, INC. logo
🇯🇵Japan
Ownership
Subsidiary
Established
2005-12-14
Employees
-
Market Cap
-
Website
http://www.cics.jp

Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma

Not Applicable
Completed
Conditions
Angiosarcoma
Malignant Melanoma
Interventions
Other: CICS-1 (investigational device),SPM-011(investigational drug)
First Posted Date
2020-03-03
Last Posted Date
2023-02-08
Lead Sponsor
Cancer Intelligence Care Systems, Inc.
Target Recruit Count
10
Registration Number
NCT04293289
Locations
🇯🇵

National Cancer Center Hospital, Chuo Ku, Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath